Quarterly report pursuant to Section 13 or 15(d)

Derivative Liabilities (Details Narrative)

v3.7.0.1
Derivative Liabilities (Details Narrative) - USD ($)
3 Months Ended
Mar. 31, 2017
Dec. 31, 2016
Derivative Instruments and Hedging Activities Disclosure [Abstract]    
Number of warrants exercisable into shares of common stock 9,212,000 9,212,000
Warrants term 5 years  
Warrants exercise price per share $ 0.01  
Derivative liability $ 175,577 $ 280,316
Derivative liability decreased during period $ 104,739